Seeking Alpha

Accretive Health (AH +1%) is still poised to generate strong growth despite the loss of its...

Accretive Health (AH +1%) is still poised to generate strong growth despite the loss of its Fairview Health Systems revenue cycle contract, says JPMorgan. The firm says the underlying franchise is attractive, noting the settlement of Minnesota's lawsuit against the company could provide a positive catalyst for the stock over the next few months.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)